All News

Pharmacists are well positioned to screen for diversion, monitor for opioid use disorder, and educate patients on opioid-related risks.

VAX-24 elicited substantial immunoglobulin G (IgG) and opsonophagocytic assay (OPA) immune responses at 1-month after the third dose across all doses studied.

There were no statistically significant differences between cognitive behavioral therapy and mindfulness-based therapy in reducing the dosage for chronic lower back pain.

In a comprehensive review, researchers aimed to explore seasonality, environmental factors, and the genetic and epigenetic mechanisms of patients living with psoriasis vulgaris.

Further studies are needed to further confirm the association between glucagon-like peptide 1 medication and reductions in dementia risk.

In a review of skin inflammation’s link to food allergen sensitivity, researchers explored how patients with atopic dermatitis may be more susceptible to the development of food allergies.

In part 3 of our interview with Jenny Markell, BA, she discussed drug advertising trends among Alzheimer’s disease drugs and how FDA suggestions are not necessarily followed.

Conflicting study findings show various associations between asthma and COVID-19; further data are needed.

Technology, such as continuous glucose monitors, changes the way patients are treated, but more work needs to be done for racial, ethnic, and socioeconomic disparities.

Researchers explored various types of self-expression among pharmacists and how they were associated with experience in community pharmacy-led deprescribing.

This year’s conference is taking place from April 10 to 12 in Austin, Texas.

Texas reports over 480 cases of measles and 2 measles-related deaths, with 1 including an unvaccinated pediatric patient.

In a conversation with David Blair, CEO of LucyRx, he discussed his company’s unique business model and how it is giving back to patients, providers, and plan sponsors alike.

Type 1 diabetes can cause long-term complications, including the development of autoimmune diseases.

Technological evolution promises to enhance patient care, reduce errors, and provide intelligent support that augments human expertise rather than replacing it.

Clinical pharmacists counsel patients during the intervention and make informed medication changes based on the data received from continuous glucose monitoring (CGM).

Pharmacists can also provide education across all pillars of health, including exercise, wellness, and dietary changes.

Researchers conducted a study to understand how community pharmacist referrals translated to the acceptance and completion of annual wellness visits.

Patients treated with the therapy showed significantly less progression of structural damage compared to patients who received placebo at week 24.

Jenny Markell, BA, discussed the ongoing trends in prescription drug advertising and touched on her research into the impact it has on consumers.

Researchers explored how entrustable professional activities can revolutionize workplace-based training and evolve the role of pharmacists within dermatology clinics.

As pharmacists adapt to patient needs, pharmacists' mental wellness remains critical.

Pharmacists are transforming health care delivery by breaking down traditional barriers to medication access and patient care.

A majority of donors said that environmental concerns were an extremely important reason to practice safe medication disposal.

With expertise in the management and treatment of diabetes, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, shared her insights on counseling patients using GLP-1 medications.

Experts discuss the evolving landscape of pharmacy through technological advancements, professional development, and advocacy.

Researchers wanted to understand the distribution of pneumococcal conjugate vaccine serotypes and how they have potential to impact pneumococcal disease severity and burden.

Previous research shows herpes zoster is associated with a higher long-term risk of subjective cognitive decline, with increased risk for men who carried APOE ε4.

As over-the-counter birth control becomes increasingly available, pharmacists are uniquely positioned to bridge critical gaps in reproductive health care.

As of April 2, 2025, liraglutide remained in shortage, with the drug first entering the FDA database on July 18, 2023.